VHL and metastatic neoplasm: Blansfield et al. suggested in 2007 that mutations in exon 3 of the VHL Suppressor Gene are related to a higher risk of malignant neuroendocrine pancreatic neoplasms, a higher risk of metastatic disease, and larger tumors7.